完善药品监管和俄罗斯药品出口

Z. A. Aladysheva, V. Beregovykh, A. P. Meshkovskiy, N. Pyatigorskaya
{"title":"完善药品监管和俄罗斯药品出口","authors":"Z. A. Aladysheva, V. Beregovykh, A. P. Meshkovskiy, N. Pyatigorskaya","doi":"10.21686/2073-1051-2023-4-157-183","DOIUrl":null,"url":null,"abstract":"Strategy on development of the pharmaceutical industry for the period up to 2030 (Pharma-2030 Strategy), adopted in the Russian Federation this year, includes tasks to further saturate the national market with domestic medicines and to “realize the export potential of the pharmaceutical industry”. National drug regulation has a significant stimulating effect on the export of medicines. To identify the most important elements of this regulation related to the development and maintenance of sustainable pharmaceutical export, different aspects of national drug regulatory systems were studied. Countries belonging to different segments of the global pharmaceutical export market were included in the research. The results of the analysis of drug regulation in top export countries were published earlier. This article presents the results for pharmerging countries with a fastgrowing pharmaceutical sector and formulated common strategies for these countries that are aimed at achieving leadership positions of the national pharmaceutical industry in both the domestic and foreign markets. Several measures have been proposed for inclusion in the implementation plan for the Pharma-2030 Strategy, which, in our opinion, will contribute to achieving the goals set both to stimulate exports and to saturate the Russian market with domestic medicines.","PeriodicalId":505601,"journal":{"name":"Federalism","volume":"9 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Refinement of Drug Regulation and Russian Pharmaceutical Export\",\"authors\":\"Z. A. Aladysheva, V. Beregovykh, A. P. Meshkovskiy, N. Pyatigorskaya\",\"doi\":\"10.21686/2073-1051-2023-4-157-183\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Strategy on development of the pharmaceutical industry for the period up to 2030 (Pharma-2030 Strategy), adopted in the Russian Federation this year, includes tasks to further saturate the national market with domestic medicines and to “realize the export potential of the pharmaceutical industry”. National drug regulation has a significant stimulating effect on the export of medicines. To identify the most important elements of this regulation related to the development and maintenance of sustainable pharmaceutical export, different aspects of national drug regulatory systems were studied. Countries belonging to different segments of the global pharmaceutical export market were included in the research. The results of the analysis of drug regulation in top export countries were published earlier. This article presents the results for pharmerging countries with a fastgrowing pharmaceutical sector and formulated common strategies for these countries that are aimed at achieving leadership positions of the national pharmaceutical industry in both the domestic and foreign markets. Several measures have been proposed for inclusion in the implementation plan for the Pharma-2030 Strategy, which, in our opinion, will contribute to achieving the goals set both to stimulate exports and to saturate the Russian market with domestic medicines.\",\"PeriodicalId\":505601,\"journal\":{\"name\":\"Federalism\",\"volume\":\"9 7\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Federalism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21686/2073-1051-2023-4-157-183\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Federalism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21686/2073-1051-2023-4-157-183","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

俄罗斯联邦今年通过了《2030 年前制药业发展战略》(《制药-2030 战略》),其中包括进一步饱和国内药品市场和 "发挥制药业出口潜力 "的任务。国家药品法规对药品出口具有显著的促进作用。为了确定这一法规中与发展和保持可持续药品出口有关的最重要因素,我们对国家药品监管体系的不同方面进行了研究。属于全球药品出口市场不同部分的国家都被纳入了研究范围。对主要出口国药品监管的分析结果已于早些时候公布。本文介绍了制药业快速增长国家的结果,并为这些国家制定了共同战略,旨在使本国制药业在国内外市场上都处于领先地位。我们认为,这些措施将有助于实现刺激出口和使俄罗斯国内药品市场饱和的目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Refinement of Drug Regulation and Russian Pharmaceutical Export
Strategy on development of the pharmaceutical industry for the period up to 2030 (Pharma-2030 Strategy), adopted in the Russian Federation this year, includes tasks to further saturate the national market with domestic medicines and to “realize the export potential of the pharmaceutical industry”. National drug regulation has a significant stimulating effect on the export of medicines. To identify the most important elements of this regulation related to the development and maintenance of sustainable pharmaceutical export, different aspects of national drug regulatory systems were studied. Countries belonging to different segments of the global pharmaceutical export market were included in the research. The results of the analysis of drug regulation in top export countries were published earlier. This article presents the results for pharmerging countries with a fastgrowing pharmaceutical sector and formulated common strategies for these countries that are aimed at achieving leadership positions of the national pharmaceutical industry in both the domestic and foreign markets. Several measures have been proposed for inclusion in the implementation plan for the Pharma-2030 Strategy, which, in our opinion, will contribute to achieving the goals set both to stimulate exports and to saturate the Russian market with domestic medicines.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信